Timm Finnegan

02) and number of lymph nodes removed (5.5 vs 9, P=.002) were lower for SP-RALRP. In the pooled analysis, 208 patients receiving SP-RALRP had similar estimated blood loss and complication rates but fewer lymph nodes removed (P=.02) and marginally longer operating time (+16 minutes, P=.01) compared to standard RALRP. The difference in rate of…[Read more]

In these settings, PCR-based assays are usually restricted to research and they are not currently helpful in the management of clinical malaria. Other technologies, such as isothermal methods could be an interesting and alternative approach to PCR in the future.

Light microscopy is still considered the gold standard method for malaria diagnosis…[Read more]

t of terahertz spectroscopy is far less than that of Raman spectroscopy, and it is easier for operator to accurately quantify microalgae lipid. In addition, it is still in early stage for the study of microalgae using terahertz spectroscopy technology, there is still much potential for us to explore.

In this article, we demonstrated the…[Read more]

Currently, metabolic syndrome has become a global health problem. Alterations in neurocognitive functions among patients with metabolic syndrome are important issues in this disorder. In this paper, studies on metabolic syndrome were reviewed and their importance emphasized for the benefit of experts and policy makers. Metabolic syndrome activates…[Read more]

The strength of evidences will be evaluated according to the Grading of Recommendations Assessment, Development and Evaluation approach. Review Manager V.5.3 software will be used for data analyses. Meta-analyses will be performed if the data are sufficiently homogeneous. The primary outcomes will be objective response rate and overall survival.…[Read more]

0001). Total radiation dose (419.3 ± 317.9 vs 998.3 ± 673 mGy, p less then 0.0001) and contrast administration (83.2 ± 22.3 mL vs 191.6 ± 33.4 mL, p less then 0.0001) were significantly lower in control group. There was no significant difference in 2-year success rate, 35.2% of patients had AF recurrence in the 3DRA group and 30.3% in the con…[Read more]